SCHEMBL6265153

SCHEMBL6265153

CCCCCCCCCCCCCCSCC(=O)SCCC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 6/20 0.64
GMNN O75496 1/20 0.64
TP53 P04637 1/20 0.64
POLB P06746 1/20 0.64
MAPT P10636 1/20 0.64
THRB P10828 1/20 0.64
CYP2C9 P11712 1/20 0.64
BLM P54132 1/20 0.64
HSD17B10 Q99714 1/20 0.64
CES1 P23141 8/20 0.56
FAAH O00519 4/20 0.56
PLA2G6 O60733 1/20 0.56
CA2 P00918 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
EPHX1 P07099 1/20 0.40
PLA2G4B P0C869 1/20 0.38
ACHE P22303 2/20 0.38
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14182500 0.78 CES2 (0.69) CES2GMNNTP53POLBMAPT
SCHEMBL4649866 0.78 HSD17B10 (1.00) CES2GMNNTP53POLBMAPT
Tetradecylthioacetic Acid SCHEMBL207756 0.78 HSD17B10 (1.00) CES2GMNNTP53POLBMAPT
SCHEMBL8980082 0.78 CES2 (1.00) CES2GMNNTP53POLBMAPT
SCHEMBL4814083 0.78 HSD17B10 (1.00) CES2GMNNTP53POLBMAPT
SCHEMBL1405566 0.78 HSD17B10 (1.00) CES2GMNNTP53POLBMAPT
SCHEMBL4354732 0.78 HSD17B10 (1.00) CES2GMNNTP53POLBMAPT
SCHEMBL7747953 0.78 CES2 (0.69) CES2GMNNTP53POLBMAPT
SCHEMBL21494396 0.78 CES2 (0.69) CES2GMNNTP53POLBMAPT
SCHEMBL1405316 0.78 HSD17B10 (1.00) CES2GMNNTP53POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1596845-A1 THERAPEUTIC USE OF ACYL GLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEROF Genfit (FR) 2005-11-23 EP disclosed
WO-2004073698-A1 THERAPEUTIC USE OF ACYL GLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEROF GENFIT (FR) 2004-09-02 WO disclosed